For the Culture By The Culture
Cannabis rescheduling keeps resurfacing in headlines, then vanishing without action. This feature breaks down how federal officials repeatedly float reform language, let deadlines pass, and leave the law untouched. By tracing the mechanics behind the stall, the piece exposes why delay is intentional, who benefits from it, and why cannabis reform remains trapped in federal limbo.
A hundred years after the 1925 International Opium Convention first outlawed cannabis, prohibition still stands as one of the biggest policy failures in modern history. From colonial fear and racist propaganda to Nixon’s drug war and global treaties, the cost has been human lives, stolen freedom, and wasted truth. The plant survived. The lies didn’t.
The MORE Act is back in Congress, aiming to remove cannabis from the Controlled Substances Act, expunge federal convictions, and create a fair federal framework. With public support at record highs and billions wasted on prohibition, this bill could finally align federal law with reality and set the stage for true reform across all 50 states.
Nearly 90% of Americans support marijuana legalization, yet arrests for cannabis possession continue across the country. With over 200,000 weed arrests in 2023 alone and deep racial disparities in enforcement, public opinion clearly isn't setting policy. This report digs into the myth of legalization and the brutal reality still unfolding on the ground.
Mike Tyson just launched a full-court press on the federal weed system. Joined by athletes and artists, he’s demanding President Trump reschedule cannabis, release prisoners, and stop treating legal operators like criminals. The DEA is stalling. Congress is hiding. The champ is not. This is the culture punching back, one haymaker at a time.
The DEA is delaying the rescheduling of marijuana from Schedule I, despite overwhelming scientific support and recommendations from health authorities. This stalling harms the cannabis industry, patients, and communities affected by marijuana criminalization. Political influences from big pharmaceutical companies contribute to this resistance, prolonging the adverse effects of current drug policies.
